Resumen
The sixth update of the Canadian Stroke Best Practice Recommendations for Transitions and Community Participation following Stroke is a comprehensive set of evidence-based guidelines addressing issues faced by people following an acute stroke event. Establishing a coordinated and seamless system of care that supports progress achieved during the initial recovery stages throughout the transition to the community is more essential than ever as the medical complexity of people with stroke is also on the rise. All members of the health-care team engaged with people with stroke, their families, and caregivers are responsible for partnerships and collaborations to ensure successful transitions and return to the community following stroke. These guidelines reinforce the growing and changing body of research evidence available to guide ongoing screening, assessment, and management of individuals following stroke as they move from one phase and stage of care to the next without “falling through the cracks.” It also recognizes the growing role of family and informal caregivers in providing significant hours of support that disrupt their own lives and responsibilities and addresses their support and educational needs. According to Statistics Canada, in 2012, eight million Canadians provided care to family members or friends with a long-term health condition, disability, or problems associated with aging. These recommendations incorporate aspects that were previously in the rehabilitation module for the purposes of streamlining, and both modules should be reviewed in order to provide comprehensive care addressing recovery and community reintegration and participation. These recommendations cover topics related to support and education of people with stroke, families, and caregivers during transitions and community reintegration. They include interprofessional planning and communication, return to driving, vocational roles, leisure activities and relationships and sexuality, and transition to long-term care.
Idioma original | English |
---|---|
Páginas (desde-hasta) | 789-806 |
Número de páginas | 18 |
Publicación | International Journal of Stroke |
Volumen | 15 |
N.º | 7 |
DOI | |
Estado | Published - oct. 1 2020 |
Nota bibliográfica
Funding Information:The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Robert Teasell receives research grant funding and speaker honorarium from Allergan, and hold a research grant from the Heart & Stroke Canadian Partnership for Stroke Recovery examining the role of Prozac in stroke recovery; Nancy Salbach holds a mid-career award and grant funding from Heart & Stroke Canadian Partnership for Stroke Recovery; Rebecca Bower works for ICAN Independence Centre and Network; Leanne K Casaubon was advisory committee member and received speaker honorarium from Bayer (2018), Independent neurological assessor, Surtavi Trial supported by Medtronic, and is Site PI for the Frontier Trial and a sub-investigator at our site for other trials related to NA1 by NoNo Inc; Dar Dowlatshahi received honoraria from Bayer, BMS, Apopharma; Gord Gubitz is a member of the advisory boards for Bayer, Boehringer Ingelheim, and Pfizer; Annie Rochette is a member of the Heart & Stroke Mission Advisory Council on Stroke, a member of the Canadian Partnership for Stroke Recovery Priority and Planning Committee, and received funding to support StrokEngine research and resource platform. The remaining authors have no conflicts of interest to declare: Anita Mountain, Jill I Cameron, M Patrice Lindsay, Norine Foley, Naresh Bains, Sanjit Bhogal, Donna Cheung, Hélène Corriveau, Lynn Joseph, Dana Lesko, Anne Millar, Beena Parappilly, Aleksandra Pikula, David Scarfone, Trudy Taylor, Tina Vallentin.
Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The development of the Canadian Stroke Best Practice Recommendations is funded in its entirety by the Heart and Stroke Foundation, Canada. No funds for the development of these guidelines come from commercial interests, including pharmaceutical and device companies. All members of the recommendation writing groups and external reviewers are volunteers and do not receive any remuneration for participation in guideline development, updates, and reviews.
Publisher Copyright:
© 2020 World Stroke Organization.
ASJC Scopus Subject Areas
- Neurology
PubMed: MeSH publication types
- Journal Article
- Research Support, Non-U.S. Gov't